NDC 65597-406-01
Enhertu 100 mg/5mL
fam-trastuzumab deruxtecan-nxki · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Enhertu is a prescription injection used to treat certain types of breast cancer that have specific genetic markers. It works by combining an antibody with a chemotherapy agent to target and destroy cancer cells.
Key Facts
- Brand Name
- Enhertu
- Generic Name
- fam-trastuzumab deruxtecan-nxki
- NDC Code (Package)
65597-406-01- NDC Code (Product)
65597-406- Manufacturer
- Daiichi Sankyo Inc.
- Strength
- 100 mg/5mL
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761139
- Marketing Start
- 12/20/2019
Recall History
No Recall HistoryView Full Drug Page
Enhertu — All PackagesNot medical advice. This information is for reference only. Always consult your doctor or pharmacist.